Inflarx N.V. balance sheet

At the end of fiscal 2025, Inflarx N.V. had total assets of $64.8m, total liabilities of $16.0m and shareholders' equity of $8.4m. It held $18.8m in cash against $0 of debt: net cash of $18.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Inflarx N.V.: balance sheet, annual
Fiscal year	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	14	19	19
Inventory	13	7	—
Total current assets	121	74	63
Total assets	133	79	65
Total current liabilities	19	15	15
Total debt	0	0	0
Total liabilities	19	15	16
Shareholders' equity	8	8	8
Non-controlling interests and other (assets − liabilities − equity)	105	56	40
Net debt (negative = net cash)	−14	−19	−19

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IFRX vs LYEL AIM vs IFRX IBIO vs IFRX

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Inflarx N.V.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inflarx N.V.